Schizophrenia and depression: The relation between sleep quality and working memory

Noort, Maurits van den; Struys, Esli; Perriard, Benoît; Staudte, Heike; Lim, Sabina; Bosch, Peggy

doi:10.1016/j.ajp.2016.08.023

Cited by 23 publications

(11 citation statements)

References 24 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…[ 18 ] In the meantime, a good sleep can improve memory and daily living ability. [ 19 ] Meanwhile, sleep disorder is not conducive to mental rehabilitation in patients with schizophrenia. [ 20 ] Acupuncture can effectively improve the quality of life of patients with mental illness, especially sleep quality, [ 21 ] thereby to correct their psychiatric symptoms.…”

Section: Discussionmentioning

confidence: 99%

Electro-acupuncture improves psychiatric symptoms, anxiety and depression in methamphetamine addicts during abstinence

Zeng

Tao²,

Hou³

et al. 2018

Medicine

View full text Add to dashboard Cite

Background:It aimed to observe the effect of electro-acupuncture on the improvement of psychiatric symptoms, as well as anxiety and depression in methamphetamine (MA) addicts during abstinence using randomized controlled trials.Methods:All patients in the present study received compulsory drug detoxification in Shanghai Drug Rehabilitation Center. All patients were enrolled consecutively from June 2014 to February 2015; data collection was completed in March 2015. According to the randomized, single-blind and control principle, 68 men MA addicts were randomly divided into 2 groups: electro-acupuncture (EA) and sham electro-acupuncture (sham-EA) groups. Patients were given 20 minutes EA or sham-EA treatment every Monday, Wednesday, and Friday, with a total of 4 weeks. Positive and Negative Syndrome Scale (PANSS), Hamilton Anxiety Scale (HAMA), and Hamilton Depression Scale (HAMD) were used to evaluate the patients’ psychotic symptoms, anxiety and depression before treatment and after receiving treatment with 1 to 4 weeks, respectively.Results:EA could effectively improve the symptoms of psychosis, anxiety, and depression during abstinence in patients with MA addiction. In terms of PANSS score, the scores for positive symptoms and general psychopathological symptoms in patients after receiving 1 to 4 weeks of treatment were significantly decreased compared with the control group, while the score for negative symptoms was significantly decreased after receiving 2 and 4 weeks of treatment. For the HAMA score, the psychotic anxiety scores in patients receiving 1 to 4 weeks of treatment were significant lower than the control group. In terms of HAMD score, there was a significant reduction in anxiety/somatization and sleep disturbance scores after the 4 weeks of EA treatment.Conclusion:Electroacupuncture helps to improve psychiatric symptoms and anxiety and depression in MA addicts during abstinence, and promote rehabilitation of patients.

show abstract

Section: Discussionmentioning

confidence: 99%

Electro-acupuncture improves psychiatric symptoms, anxiety and depression in methamphetamine addicts during abstinence

Zeng

Tao²,

Hou³

et al. 2018

Medicine

View full text Add to dashboard Cite

show abstract

“…Impairment of WM is common in a range of psychiatric disorders including SZ and MDD and the severity of the deficit depends on diagnosis (Forbes, Carrick, McIntosh, & Lawrie, 2009; Lever, Werkle‐Bergner, Brandmaier, Ridderinkhof, & Geurts, 2015; Schwarz, Tost, & Meyer‐Lindenberg, 2016; Snyder, 2013; Yamashita et al, 2018), with greater impairments associated with higher values of a factor representing general psychopathology (Caspi et al, 2014). In the case of SZ, there have been consistent reports, including those in reviews, of the existence of WM impairment in patients relative to healthy controls (HC) (Barch & Sheffield, 2014; Kaminski et al, 2020; Kim, Glahn, Nuechterlein, & Cannon, 2004; Mayer, Stablein, Oertel‐Knochel, & Fiebach, 2018; Noort et al, 2016; Park & Gooding, 2014; Piskulic, Olver, Norman, & Maruff, 2007; Pu et al, 2019; Schaefer, Giangrande, Weinberger, & Dickinson, 2013; Schlagenhauf et al, 2008; Trapp et al, 2017). On the other hand, in the case of MDD, relative to HC, WM performance has sometimes been reported to be impaired (Chen et al, 2018; Christopher & MacDonald, 2005; Egeland et al, 2003; Liu et al, 2019; Noort et al, 2016; Pu et al, 2011; Pu et al, 2018; Schwert, Stohrer, Aschenbrenner, Weisbrod, & Schröder, 2019) or sometimes not (Channon, Baker, & Robertson, 1993; Murphy et al, 2019; Trapp et al, 2017; Yuksel et al, 2018).…”

Section: Introductionmentioning

confidence: 89%

“…In the case of SZ, there have been consistent reports, including those in reviews, of the existence of WM impairment in patients relative to healthy controls (HC) (Barch & Sheffield, 2014; Kaminski et al, 2020; Kim, Glahn, Nuechterlein, & Cannon, 2004; Mayer, Stablein, Oertel‐Knochel, & Fiebach, 2018; Noort et al, 2016; Park & Gooding, 2014; Piskulic, Olver, Norman, & Maruff, 2007; Pu et al, 2019; Schaefer, Giangrande, Weinberger, & Dickinson, 2013; Schlagenhauf et al, 2008; Trapp et al, 2017). On the other hand, in the case of MDD, relative to HC, WM performance has sometimes been reported to be impaired (Chen et al, 2018; Christopher & MacDonald, 2005; Egeland et al, 2003; Liu et al, 2019; Noort et al, 2016; Pu et al, 2011; Pu et al, 2018; Schwert, Stohrer, Aschenbrenner, Weisbrod, & Schröder, 2019) or sometimes not (Channon, Baker, & Robertson, 1993; Murphy et al, 2019; Trapp et al, 2017; Yuksel et al, 2018). Furthermore, WM deficits have been reported to increase over time in SZ (Fu, Czajkowski, & Torgalsboen, 2018; Jimenez‐Lopez et al, 2019; Park, Püschel, Sauter, Rentsch, & Hell, 1999; Strugstad, Lau, & Glenne Oie, 2018), but not in MDD (Nuninga et al, 2018; Sankar, Adams, Costafreda, Marangell, & Fu, 2017; Vasavada et al, 2017; Zuidersma, Comijs, Naarding, & Oude Voshaar, 2016).…”

Section: Introductionmentioning

confidence: 89%

Shared and distinct brain fMRI response during performance of working memory tasks in adult patients with schizophrenia and major depressive disorder

Wang

Cheng

Roberts

et al. 2021

Human Brain Mapping

View full text Add to dashboard Cite

Working memory (WM) impairments are common features of psychiatric disorders. A systematic meta‐analysis was performed to determine common and disorder‐specific brain fMRI response during performance of WM tasks in patients with SZ and patients with MDD relative to healthy controls (HC). Thirty‐four published fMRI studies of WM in patients with SZ and 18 published fMRI studies of WM in patients with MDD, including relevant HC, were included in the meta‐analysis. In both SZ and MDD there was common stronger fMRI response in right medial prefrontal cortex (MPFC) and bilateral anterior cingulate cortex (ACC), which are part of the default mode network (DMN). The effects were of greater magnitude in SZ than MDD, especially in prefrontal‐temporal‐cingulate‐striatal‐cerebellar regions. In addition, a disorder‐specific weaker fMRI response was observed in right middle frontal gyrus (MFG) in MDD, relative to HC. For both SZ and MDD a significant correlation was observed between the severity of clinical symptoms and lateralized fMRI response relative to HC. These findings indicate that there may be common and distinct anomalies in brain function underlying deficits in WM in SZ and MDD, which may serve as a potential functional neuroimaging‐based diagnostic biomarker with value in supporting clinical diagnosis, measuring illness severity and assessing the efficacy of treatments for SZ and MDD at the brain level.

show abstract

“…Moreover, Pearson correlation analyses (two-tailed) were used to test for a possible linear relationship between the patient’s subjective quality of sleep and the patient’s pharmacological treatment. For all statistical analyses, a significance level of p < 0.05 was used [ 47 ].…”

Section: Methodsmentioning

confidence: 99%

Pharmacological Treatment for Long-Term Patients with Schizophrenia and Its Effects on Sleep in Daily Clinical Practice: A Pilot Study

et al. 2018

Self Cite

View full text Add to dashboard Cite

Background: Pharmacological treatment is still the key intervention in the disease management of long-term patients with schizophrenia; however, how it affects sleep and whether gender differences exist remains unclear. Methods: Forty-six long-term outpatients with schizophrenia entered the study. The numbers of antipsychotics, sleep medications, antidepressants, and anxiolytics were analyzed. Moreover, all patients were tested using the Pittsburgh Sleep Quality Index (PSQI) and the Epworth Sleepiness Scale (ESS). Correlation analyses were conducted between the medication used and the scores on the two subjective sleep inventories. Results: A large variability, ranging from 0 to 8, in the total number of psychiatric drugs per person was found between the patients. Despite ongoing pharmacological treatment, the patients scored high on the PSQI, but not on the ESS; this indicates that they report problems with sleep, but not with daytime sleepiness. A significant positive correlation between the use of antipsychotics and the ESS score, but not the PSQI score, was found; moreover, no gender differences were found. Conclusions: A large variability exists in the pharmacological treatment of long-term patients with schizophrenia. To date, patients’ sleep problems have been insufficiently treated, and gender differences have not been adequately accounted for in the pharmacological treatment of schizophrenia. More and larger international clinical studies are warranted to verify the findings of the present preliminary pilot study before any firm conclusions can be drawn and before any changes to the drug treatment of male and female patients with schizophrenia can be recommended.

show abstract

Schizophrenia and depression: The relation between sleep quality and working memory

Cited by 23 publications

References 24 publications

Electro-acupuncture improves psychiatric symptoms, anxiety and depression in methamphetamine addicts during abstinence

Electro-acupuncture improves psychiatric symptoms, anxiety and depression in methamphetamine addicts during abstinence

Shared and distinct brain fMRI response during performance of working memory tasks in adult patients with schizophrenia and major depressive disorder

Pharmacological Treatment for Long-Term Patients with Schizophrenia and Its Effects on Sleep in Daily Clinical Practice: A Pilot Study

Contact Info

Product

Resources

About